| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2017-02-24 |
复牌提示：
2017-02-24 08:22:57 停牌，复牌日期 2017-02-27 00:00:01
|
| 2017-02-24 |
详情>>
内部人交易：
NAVARRO SAMUEL E等共交易13笔
|
| 2016-11-09 |
详情>>
股本变动：
变动后总股本2826.92万股
|
| 2016-11-09 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-0.04美元,归母净利润-116.68万美元,同比去年增长95.96%
|
| 2016-08-08 |
详情>>
业绩披露：
2016年中报每股收益0.01美元,归母净利润22.48万美元,同比去年增长101.13%
|
| 2016-05-10 |
详情>>
业绩披露：
2016年一季报每股收益-0.07美元,归母净利润-175.78万美元,同比去年增长83.43%
|
| 2016-04-20 |
股东大会：
将于2016-06-01召开股东大会
会议内容 ▼▲
- 1.To elect five directors for the year following the Meeting or until their successors are elected;
2.To advise us as to whether you approve the compensation of our named executive officers (Say-on-Pay);
3.To consider and vote upon ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
4.To transact such other business as may properly come before the Meeting or any adjournments or postponements thereof.
|
| 2016-03-15 |
详情>>
业绩披露：
2015年年报每股收益-1.48美元,归母净利润-3810.75万美元,同比去年增长4.18%
|
| 2016-03-15 |
详情>>
业绩披露：
2013年年报每股收益-1.4美元,归母净利润-2396.41万美元,同比去年增长-98.54%
|
| 2015-11-06 |
详情>>
业绩披露：
2015年三季报(累计)每股收益-1.12美元,归母净利润-2885.81万美元,同比去年增长4.46%
|
| 2015-08-07 |
详情>>
业绩披露：
2015年中报每股收益-0.78美元,归母净利润-1989.53万美元,同比去年增长-4.95%
|
| 2015-08-07 |
详情>>
业绩披露：
2014年中报每股收益-0.79美元,归母净利润-1895.68万美元,同比去年增长-39.5%
|
| 2015-05-08 |
详情>>
业绩披露：
2015年一季报每股收益-0.42美元,归母净利润-1060.96万美元,同比去年增长-3.31%
|
| 2015-04-09 |
股东大会：
将于2015-05-27召开股东大会
会议内容 ▼▲
- 1. To elect eight directors for the year following the Meeting or until their successors are elected;
2. To advise us as to whether you approve the compensation of our named executive officers (Say-on-Pay);
3. To consider and vote upon ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
4. To transact such other business as may properly come before the Meeting or any adjournments or postponements thereof.
|
| 2015-03-11 |
详情>>
业绩披露：
2014年年报每股收益-1.62美元,归母净利润-3977.16万美元,同比去年增长-65.96%
|
| 2014-11-07 |
详情>>
业绩披露：
2014年三季报(累计)每股收益-1.24美元,归母净利润-3020.46万美元,同比去年增长-62.93%
|
| 2014-04-09 |
股东大会：
将于2014-05-20召开股东大会
会议内容 ▼▲
- 1. To elect eight directors for the year following the Meeting or until their successors are elected;
2. To consider and vote upon the proposal to amend the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 35,000,000 to 50,000,000;
3. To consider and vote upon an amendment to the Amended and Restated Derma Sciences, Inc. 2012 Equity Incentive Plan to increase the number of shares available for issuance thereunder in the amount of 1,500,000 shares, from 4,500,000 to 6,000,000 shares;
4. To advise us as to whether you approve the compensation of our named executive officers (Say-on-Pay);
5. To consider and vote upon ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
6. To transact such other business as may properly come before the Meeting or any adjournments or postponements, thereof.
|
| 2013-04-12 |
股东大会：
将于2013-05-22召开股东大会
会议内容 ▼▲
- 1. To elect eight directors for the year following the Meeting or until their successors are elected;
2. To consider and vote upon the proposal to amend the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 25,000,000 to 35,000,000;
3. To consider and vote upon an amendment to the Derma Sciences, Inc. 2012 Equity Incentive Plan to increase the number of shares available for issuance thereunder in the amount of 1,687,500 shares, from 2,812,500 to 4,500,000 shares;
4. To advise us as to whether you approve the compensation of our named executive officers (Say-on-Pay);
5. To advise us as to whether you prefer a vote to advise us on the compensation of our named executive officers every year, every two years or every three years (Say-on-Pay Frequency);
6. To consider and vote upon ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013;
7. To transact such other business as may properly come before the Meeting or any adjournments or postponements, thereof.
|